|
[1]
|
Modification of the Human Amniotic Membrane Using Different Cross-Linking Agents as a Promising Tool for Regenerative Medicine
Materials,
2023
DOI:10.3390/ma16206726
|
|
|
|
|
[2]
|
Modulation of autophagy as the target of mesenchymal stem cells-derived conditioned medium in rat model of myocardial ischemia/reperfusion injury
Molecular Biology Reports,
2021
DOI:10.1007/s11033-021-06359-0
|
|
|
|
|
[3]
|
Human amniotic membrane mesenchymal stem cell‐conditioned medium reduces inflammatory factors and fibrosis in ovalbumin‐induced asthma in mice
Experimental Physiology,
2021
DOI:10.1113/EP088911
|
|
|
|
|
[4]
|
Amniotic membrane as novel scaffold for human iPSC-derived cardiomyogenesis
In Vitro Cellular & Developmental Biology - Animal,
2019
DOI:10.1007/s11626-019-00321-y
|
|
|
|
|
[5]
|
Current Progress in Tendon and Ligament Tissue Engineering
Tissue Engineering and Regenerative Medicine,
2019
DOI:10.1007/s13770-019-00196-w
|
|
|
|
|
[6]
|
Current Developments in Biotechnology and Bioengineering
2017
DOI:10.1016/B978-0-444-63660-7.00014-0
|
|
|
|
|
[7]
|
Decellularized Amniotic Membrane Scaffold as a Pericardial Substitute: An In Vivo Study
Transplantation Proceedings,
2016
DOI:10.1016/j.transproceed.2016.07.026
|
|
|
|
|
[8]
|
Stem cell death and survival in heart regeneration and repair
Apoptosis,
2016
DOI:10.1007/s10495-015-1203-4
|
|
|
|
|
[9]
|
Extracellular Matrix-Derived Implants in Clinical Medicine
2016
DOI:10.1016/B978-0-08-100166-0.00009-8
|
|
|
|